The preparation and use of [77Br]p-bromospiperone for clinical dopamine D2 receptor measurements

S.R.D. Oldland1, N. Veall1
1Divisions of Radioisotopes and Psychiatry, MRS Clinical Research Centre, Watford Rd, Harrow, Middlesex HA1 3UJ, U.K.

Tài liệu tham khảo

Owen, 1978, Lancet, ii, 223, 10.1016/S0140-6736(78)91740-3 Wagner, 1983, Science, 221, 1264, 10.1126/science.6604315 Farde, 1985, Science, 231, 258, 10.1126/science.2867601 Huang, 1980, J. Pharmac. Sci., 69, 984, 10.1002/jps.2600690835 Friedman, 1982, Int. J. Nucl. Med. Biol., 9, 57, 10.1016/0047-0740(82)90076-6 Owen, 1983, Life Sci., 33, 765, 10.1016/0024-3205(83)90782-8 Malcolme-Lawes, 1980, J. Chem. Soc. Chem. Commun., 221, 10.1039/c39800000221 Pogun, 1982, 3606 De Jesus, 1983, J. Labelled Compd. Radiopharm., 20, 745, 10.1002/jlcr.2580200609 Crawley, 1984, Radiat. Protect. Dosim., 8, 147 Snyder, 1975 1977, ICRP Publication 26, Ann. ICRP, 1, 1, 10.1016/0146-6453(76)90002-6 Crawley, 1984, Lancet, ii, 975 Crawley, 1984, Clin. Phys. Physiol. Meas., 5, 121, 10.1088/0143-0815/5/2/009 Dischino, 1983, J. Nucl. Med., 24, 1030 Smith, 1986, Clin. Sci., 70, 53p, 10.1042/cs0700053